What weekly dulaglutide does

Dulaglutide acts on GLP-1 receptors. This helps your body release insulin when glucose is high, along with other actions that improve glucose control. Dulaglutide also affects appetite and weight, but the licensed use and treatment goal come first. You use Trulicity with diet and exercise, on its own in some cases or with other diabetes medicines. Your combination depends on your wider clinical assessment.

Doses are specific to Trulicity

Trulicity comes in several strengths. Your starting dose and any increases depend on whether you take it alone or with other medicines, your age and your clinical needs. Weekly semaglutide and tirzepatide doses do not convert to Trulicity doses because all three are weekly. A switch should set out your last dose of the old medicine, your new starting dose and your next review.

Get a demonstration of the Trulicity pen

Weekly pens work in different ways. Read the leaflet for the Trulicity pen you are given and ask a pharmacist to show you how to use it. Another brand's needle fitting, priming, dose setting or hold time may not apply. Keep the packaging until you are confident with the device, and use a proper sharps disposal arrangement. Never share a pen, even with someone you live with.

Measure benefit beyond the scales

Diabetes reviews usually look at HbA1c, symptoms and risk factors, along with side effects and how much effort treatment takes. Trulicity has a large diabetes evidence base, including cardiovascular research. A study result matters to you when the trial group matches your condition. Weight loss alone gives an incomplete picture of whether a diabetes medicine works or whether a change would help.

Side effects and combined treatment

Digestive side effects happen, and persistent vomiting or diarrhoea can leave you dehydrated. Get urgent help for severe abdominal pain that will not go away. If you also take insulin or a sulfonylurea, you may need a plan to lower your risk of hypoglycaemia. Your diabetes team should make that plan. Cutting or stopping insulin suddenly causes serious problems, even if your appetite and glucose readings look better at first.

Questions for your next review

Ask which result your team is aiming for, how long to stay on the current dose before judging it, and what would justify a change. Raise injection problems, supply issues and costs before they cause gaps. Check the current UK product information, as an overseas article may describe different licensed uses or pens. If your clinician suggests an alternative, get the practical handover in writing.

One hungry day says little about a weekly medicine

Appetite changes across a week for many reasons, and hunger is not a validated way to set a diabetes dose. Bring a fuller record to your review: glucose patterns if you monitor them, digestive symptoms, missed doses and any change in how you cope day to day. Your clinician then has a sound basis for judging whether treatment is working. A single hungry day is no reason to inject early, take an extra dose or add another GLP-1 product.

Sources

Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.

  1. EMA: Trulicity assessment and product information ema.europa.eu
  2. NICE NG28: type 2 diabetes in adults nice.org.uk
  3. MHRA: GLP-1 medicines and rapid insulin reduction gov.uk

Spotted something out of date? Report a mistake.